Mr Accuracyreports has published a new research report titled “
Global Pet Vaccine Market Size By Type (Canine, Feline), By Vaccination (Canine Family, Core Vaccines, Non-Core Vaccines), By Mode of Administration (Injectable Vaccines, Intranasal Vaccines), By Geographic Scope And Forecast
” in its research database. Get a Free Sample PDF of this Research Report for more Insights with Table of Content, Research Methodology, and Graphs –
https://www.mraccuracyreports.com/marketreports/5/857146/Pet-Vaccine-Market
https://www.mraccuracyreports.com/request/download/5/857146/Pet-Vaccine-Market
Pet Vaccine Market Size And Forecast
Pet Vaccine Market size was valued at USD 7.35 Billion in 2021 and is projected to reach USD 12.98 Billion by 2030, growing at a CAGR of 6.52% from 2023 to 2030.
An increasing number of animals suffering from various diseases and an increasing livestock population of animals are some of the factors anticipated for driving the market growth during the forecast period. The Global Pet Vaccine Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Pet Vaccine Market Definition
The purpose of vaccines is to stimulate the immune system’s defense mechanisms and prime it to fight off future infections from pathogens. Vaccines encourage the immune system to produce antibodies that recognize and eliminate pathogens that enter the body. Vaccines for animals aid in defending them against a variety of deadly and serious diseases. Experts agree that the widespread use of vaccines within the last century has prevented death and disease in millions of animals even though some formerly common diseases have become uncommon.
There are two groups of vaccinations based on lifestyle and core vaccinations. Core Vaccination includes rabies, distemper, hepatitis, parvo-virus, parainfluenza, and corona, and lifestyle-based vaccination includes bordetella, leptospirosis, rattlesnake, and influenza H3N2. These vaccinations protect pets from many of the diseases that affect wildlife and particularly rabies and distemper. In many areas, local ordinances require certain vaccination of household pets.
Because they offer protection against the diseases that are most prevalent there, core vaccinations are advised for the majority of pets in a given area. Non-core vaccinations are for individual pets with unique needs. Many vaccines offer appropriate immunity when delivered every few years, while others are required more frequent frequency to maintain an acceptable degree of immunity that will safeguard the dogs.
Global Pet Vaccine Market Overview
The increasing population of companion animals, increasing product launches, and increasing zoonotic diseases are driving the growth of the Pet Vaccine Market. For example, In Oct 2019, Zoetis launched Versican Plus Bb Oral, the oral vaccine for dogs in Europe. Changing lifestyle is another driving factor because people have started adopting different animals as their companion animals like dogs, cats, horses, etc for their company or for entertainment purposes.
Moreover, technological advancements in developing pet health vaccines, favorable government initiatives, and increasing awareness about pet vaccination among people are providing growth opportunities to the market. Furthermore, increasing investment in R&D activities of vaccines for animals, for example, Ceva launched a new vaccine Cevac IBron for protecting animals against the infectious bronchitis virus in February 2017.
However, the risk of side effects and lack of infrastructure for developing vaccines can hamper the growth of the market. There are certain side effects of pet vaccines such as fever, persistent vomiting, swelling of the muzzle and nasal discharge, etc which can adversely affect the growth of the market.
Global Pet Vaccine Market: Segmentation Analysis
The Global Pet Vaccine Market is Segmented on the basis of Type, Vaccination, Mode of Administration, And Geography.
Pet Vaccine Market, By Type
- Canine
- Feline
- Others
Based on Type, The market is bifurcated into Canine, Feline, and Others. The Canine segment accounted for the largest market share due to the increasing companion animal population, the increasing importance of animal health, and changing lifestyles.
Pet Vaccine Market, By Vaccination
- Canine Family
- Core Vaccines
- Non-Core Vaccines
- Feline Family
- Others
Based on Vaccination, The market is bifurcated into Canine Family, Core Vaccines, Non-Core Vaccines, Feline Family, and Others. The core vaccine segment dominated the highest market share due to the increasing prevalence of chronic diseases in animals and the increasing approval and launch of new vaccines.
Pet Vaccine Market, By Mode of Administration
- Injectable Vaccines
- Intranasal Vaccines
Based on Mode of Administration, The market is bifurcated into Injectable Vaccines and Intranasal Vaccines. The intranasal segment dominated the highest market share due to providing faster protection, resulting in higher nasal antibody levels, less shedding of organisms, and more protection for more dogs.
Pet Vaccine Market, By Geography
- North America
- Europe
- Asia Pacific
- Rest of the world
On the basis of Regional Analysis, The Global Pet Vaccine Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America held the largest revenue share and is expected to maintain the lead throughout the forecast period owing to increasing awareness about animal healthcare and increasing investments in research and development activities for developing advanced vaccines for pet animals.
Key Players
The “Global Pet Vaccine Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Elanco, Merck &Co, Ceva, Virbac, Zoetis Inc, HIPRA, Ourofino Animal Health, Biogenesis Bago, Vetoquinol, and Merial Inc. The competitive landscape section also contains important development strategies, market share, and market ranking analysis of the above-mentioned players internationally.
Key Developments
Partnerships, Collaborations, and Agreements
- Merck Animal Health struck a collaboration agreement with Automazioni VX, Inc. in 2020. (US). This collaboration sought to introduce Innoject Pro, a newly engineered subcutaneous chick vaccination method. The technology will be used in conjunction with Merck Animal Health’s Innovax vaccine line, which is designed to protect poultry against infectious diseases.
- Pharmaq (a division of Zoetis) struck a collaboration arrangement with Caritas in 2019. (US). This collaboration aims to boost the productivity and sustainability of the country’s tilapia value chain. In addition, the cooperation will give tilapia growers training in fish health management and optimal aquaculture methods.
Mergers and Acquisitions
- Elanco inked an agreement with Bayer’s Animal Health Business in 2019 to buy its Animal Health business for USD 7.6 billion.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| STUDY PERIOD |
2018-2030 |
| BASE YEAR |
2021 |
| FORECAST PERIOD |
2023-2030 |
| HISTORICAL PERIOD |
2018-2020 |
| UNIT |
Value (USD Billion) |
| KEY COMPANIES PROFILED |
Elanco, Merck &Co, Ceva, Virbac, Zoetis Inc, HIPRA, Ourofino Animal Health, Biogenesis Bago, Vetoquinol, and Merial Inc. |
| SEGMENTS COVERED |
By Type, By Vaccination, By Mode of Administration, And By Geography. |
| CUSTOMIZATION SCOPE |
Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Top Trending Reports
Research Methodology of Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.
